絞り込み

17703

広告

Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes.

著者 Wagner S , Roberson D , Boland J , Kreimer AR , Yeager M , Cullen M , Mirabello L , Dunn ST , Walker J , Zuna R , Porras C , Cortes B , Sampson J , Herrero R , Rodriguez AC , Quint W , Van Doorn LJ , , Hildesheim A , Schiffman M , Wentzensen N
J Infect Dis.2019 Jun 26 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (16view , 0users)
Human papillomaviruses (HPV) cause over 500 000 cervical cancers each year, most of which occur in low-resource settings. Human papillomavirus genotyping is important to study natural history and vaccine efficacy. We evaluated TypeSeq, a novel, next-generation, sequencing-based assay that detects 51 HPV genotypes, in 2 large international epidemiologic studies.
PMID: 31536132 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード